Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Acurx Pharmaceuticals, Inc. (ACXP) had Non-Operating Income/Expense of $0.05M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-2.58M |
|
-- |
|
-- |
|
$2.63M |
|
$-2.63M |
|
|
Non-Operating Income/Expense |
$0.05M |
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-2.58M |
|
$-2.63M |
|
$-2.63M |
|
5.32M |
|
5.32M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$10.34M |
|
-- |
|
-- |
|
$10.34M |
|
$2.99M |
|
-- |
|
-- |
|
$2.99M |
|
$7.34M |
|
$7.34M |
|
$7.34M |
|
5.88M |
|
| Cash Flow Statement Financials | |
$-5.61M |
|
-- |
|
$7.70M |
|
$7.56M |
|
$9.65M |
|
$2.10M |
|
$0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.18% |
|
-35.18% |
|
-24.99% |
|
-35.18% |
|
$1.25 |
|
$-1.05 |
|
$-1.05 |
|